ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 112 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $703,000 | -61.2% | 195,340 | -71.1% | 0.00% | -57.1% |
| Q2 2019 | $1,814,000 | -9.5% | 676,959 | -0.1% | 0.01% | -12.5% |
| Q1 2019 | $2,005,000 | -12.3% | 677,459 | -52.9% | 0.01% | -20.0% |
| Q4 2018 | $2,287,000 | -58.3% | 1,438,113 | -3.6% | 0.01% | -50.0% |
| Q3 2018 | $5,490,000 | +30.0% | 1,491,764 | -0.0% | 0.02% | +17.6% |
| Q2 2018 | $4,223,000 | -26.8% | 1,492,264 | -4.1% | 0.02% | -34.6% |
| Q1 2018 | $5,773,000 | – | 1,556,164 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 12,033,220 | $92,896,000 | 11.87% |
| RTW INVESTMENTS, LP | 2,558,859 | $19,754,000 | 7.17% |
| TURNER INVESTMENTS LLC | 859,560 | $6,636,000 | 1.80% |
| DAFNA Capital Management LLC | 236,500 | $1,826,000 | 1.58% |
| Ghost Tree Capital, LLC | 250,000 | $1,930,000 | 1.09% |
| Orbimed Advisors | 11,519,700 | $88,932,000 | 0.94% |
| Rock Springs Capital Management LP | 1,220,000 | $9,418,000 | 0.79% |
| Opus Point Partners Management, LLC | 99,000 | $764,000 | 0.59% |
| Bellevue Group AG | 420,000 | $3,242,000 | 0.59% |
| Cormorant Asset Management, LP | 500,000 | $3,860,000 | 0.58% |